0001181431-12-042507.txt : 20120727
0001181431-12-042507.hdr.sgml : 20120727
20120727164135
ACCESSION NUMBER: 0001181431-12-042507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120725
FILED AS OF DATE: 20120727
DATE AS OF CHANGE: 20120727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seely Lynn
CENTRAL INDEX KEY: 0001327111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 12991111
MAIL ADDRESS:
STREET 1: 501 2ND STREET
STREET 2: SUITE 211
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
4
1
rrd351729.xml
LYNN SEELY -- 7/25/12 EXERCISE AND SALE
X0306
4
2012-07-25
0
0001011835
MEDIVATION, INC.
MDVN
0001327111
Seely Lynn
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Medical Officer
Common stock
2012-07-25
4
M
0
2400
34.56
A
23911
D
Common Stock
2012-07-25
4
S
0
2400
98.0077
D
21511
D
Common Stock
2012-07-26
4
M
0
37600
34.56
A
59111
D
Common Stock
2012-07-26
4
S
0
32094
99.6358
D
27017
D
Common Stock
2012-07-26
4
S
0
5506
100.2732
D
21511
D
Stock Option (Right to Buy)
34.56
2012-07-25
4
M
0
2400
0.00
D
2019-12-15
Common Stock
2400
91600
D
Stock Option (Right to Buy)
34.56
2011-07-26
4
M
0
37600
0.00
D
2019-12-15
Common Stock
37600
54000
D
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $98.00 to $98.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest of the first day of each full month thereafter.
The shares were sold at prices ranging from $98.99 to $99.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $99.99 to $100.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ C. Patrick Machado, Attorney-in-fact
2012-07-27